DexCom DXCM Treasury Stock, Value, Benefit Received From Note Hedge
Discontinued — last reported Q4 '25
Treasury Stock, Value, Benefit Received From Note Hedge at other companies
Other financials
Where this comes from
Reported directly by DexCom in its filing.
Tagged under the XBRL concept dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge.
The official record: DexCom’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about DexCom's treasury stock, value, benefit received from note hedge.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is DexCom's treasury stock, value, benefit received from note hedge?
- DexCom (DXCM) reported treasury stock, value, benefit received from note hedge of $0 in Q4 2025.
- What is the long-term trend for DexCom's treasury stock, value, benefit received from note hedge?
- Over 2 years (2021 to 2025), DexCom's treasury stock, value, benefit received from note hedge has grown at a -100.0% compound annual growth rate (CAGR), from $130.8M to $0.
- What does treasury stock, value, benefit received from note hedge mean?
- The financial gain realized from hedging instruments used to mitigate the dilutive impact of convertible debt.
- How do you interpret treasury stock, value, benefit received from note hedge?
- An increase indicates effective risk management of equity dilution and potential cash inflows from derivative settlements.
- How does treasury stock, value, benefit received from note hedge compare across companies?
- Standard disclosure for companies with significant convertible debt structures and associated hedging programs.